BioSpace News Archive

- Combined portfolio will enhance Mentice’s endovascular simulation offerings with world class replication solutions - Acquisition to expand Mentice’s global customer base and offer a strong entry into previously untapped market segments

Tamiflu-maker Hoffman-La Roche (OTCMKTS – RHHBY) must answer to whistleblower charges that it falsified claims of Tamiflu’s effectiveness in fighting influenza and fraudulently induced the federal government to stockpile millions of doses f

Medical Technology Management Institute, a division of The College of Health Care Professions, Partners with Jaguars to Provide Musculoskeletal Ultrasound Training; Receives Approval from Board of Certification for Athletic Trainers

Vireo Health International, Inc. (“Vireo” or the “Company”) (CNSX: VREO, OTCQX: VREOF), the science-focused, multi-state cannabis company with active operations in exclusively medical-only markets and licenses in seven states and the Commonwealth of Puerto Rico, today announced that it has reached a definitive agreement with Ayr Strategies Inc.

Customers Can Win $1,000 in Rite Aid Gift Cards by Recognizing Rite Aid’s Healthcare Heroes During the COVID-19 Pandemic and Beyond

Investment and trade opportunities for Saskatchewan and Canada in Bangladesh were the focus of a seminar that took place this week in Saskatoon, jointly hosted by the Bangladesh High Commission to Canada, the Global Institute for Food Security at the University of Saskatchewan and Ag-West Bio Inc.

Addition of AMAG’s category leading treatments positions Covis to become a global market leader of therapeutic solutions for life-threatening conditions and chronic illnesses Covis will commence a tender offer to acquire all the outstanding shares of AMAG for a purchase price of $13.75 per share in cash, or approximately $ 647 million, including debt obligations expected to be assumed or repaid net of cash Transaction expected to close in November 2020 post tender offer LUXEMBO

Drug- and vaccine-based methods of attacking the SARS-CoV-2 virus rely on chemical properties to identify the virus (for example surface antigens). These chemical properties can change when the virus mutates, rendering those therapies ineffective. An alternative method for identifying the virus would be to use the physical propertie

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its third quarter financial results, Thursday November 5, 2020 at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 8:00 a.m. ET. In order to participate, please dial the following numbers (at least 10 minutes before the scheduled start time): Uni

Colorado BioScience Association (CBSA) brings leaders from Colorado life sciences companies and organizations together this week for the highly anticipated Colorado Life Sciences Innovation Forum and Trade Show . The event features national and Colorado thought leaders highlighting the most pressing and relevant topics for Colorado’s health inno